BioSpace News Archive

WINLEVI is the first and only topical Androgen Receptor Inhibitor, and the newest Health Canada-approved formulation to target the hormonal component of acne in 40 years.

Galvanize Therapeutics, Inc. has completed enrollment in the RheSolve pivotal trial evaluating the RheOx ® Bronchial Rheoplasty System as a treatment for chronic bronchitis symptoms.

Millar, the industry leader in research pressure measurements and global OEM solutions partner, announces that it will be guiding pressure-volume (PV) loop technology into the future by combining its market-leading catheter solutions with Transonic Scisense’s Admittance-based pressure-volume (PV) loop systems.

FemAid, A pioneering Medical Devise company dedicated to empowering woman’s health, is pleased to announce a major achievement in the development of its groundbreaking prototyping phase and patent filing application, marking a significant step towards revolutionizing the management of urinary incontinence in women.

Ascelia Pharma AB (publ) (ticker: ACE), a biotech focused on improving the life of people living with rare cancer conditions, today announced that data from the company’s Hepatic Impairment Study were presented at the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) Annual Meeting in Valencia, Spain, June 13-16, 2023.

Sequana Medical NV (Euronext Brussels: SEQUA, the “Company” or “Sequana Medical”) today announces that data from POSEIDON, its North American pivotal study of the alfapump will be presented during two poster sessions at the EASL Congress 2023, taking place in Vienna, Austria from 21 to 24 June 2023.

Auxilius Pharma has consolidated its financing for developing its lead asset, AUX-001, an innovative new medication for treating chronic-stable angina pectoris in the US, a condition affecting 11 million Americans over the age of 20.[1] The company raised late last year USD 1MM in a seed financing round led EU based by venture capital fund CofounderZone.

The controversial 2022 video Died Suddenly has sparked devastating criticisms from both COVID vaccine proponents and skeptics, but the question remains: Are the vaccines a potential cause of otherwise unexplained sudden death? In the summer issue of the Journal of American Physicians and Surgeons, Jane Orient, M.D., explores possible causes of this terrifying event.

The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, has signed a Memorandum of Understanding (MoU) with AbbVie Biopharmaceutical and M42 to elevate collaborative efforts in tailoring personalised medicine and genomics in Abu Dhabi, the capital of the United Arab Emirates (UAE).

Curocell Inc, a Korea-based clinical-stage CAR-T cell therapy company, announced updated Phase 2 interim results for Anbalcabtagene-autoleucel (anbal-cel) on June 15, 2023, at ICML (International Conference on Malignant Lymphoma), Lugano, Switzerland.